Iran to quintuple anticancer nano-drug exports to Syria

Iran to quintuple anticancer nano-drug exports to Syria

CEO of an Iranian knowledge-based company active in producing anticancer nano-drugs said the company is planning to increase its exports to Syria fivefold in the current Iranian year.

 

 
Mahnaz Ghomi, CEO of the knowledge-based company active in producing the anticancer drug ‘SinaDoxosome’, told Mehr News that they have been producing the anticancer drugs through nanotechnology since 2011.
اخبار مرتبط

0نظر

ارسال نظر